Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,497,774
-$504,707 QoQ
Shares Held
25,994
-21.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#959
of 2,521 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Larson Financial Group LLC holds $64,664,035 across 17 Drug Manufacturers - General names. BMY ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
21,831 | $26,184,758 | |
| 2 | ABBV |
AbbVie Inc.
|
35,918 | $9,038,405 | |
| 3 | MRK |
Merck & Co., Inc.
|
63,932 | $8,215,262 | |
| 4 | PFE |
Pfizer Inc
|
310,250 | $7,470,820 | |
| 5 | JNJ |
Johnson & Johnson
|
27,845 | $7,071,794 | |
| 6 | AMGN |
Amgen Inc
|
7,025 | $2,543,893 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
25,994 | $1,497,774 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
11,716 | $1,480,199 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,497,774 | 25,994 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,002,481 | 33,017 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,558,326 | 28,890 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,274,300 | 28,255 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,501,138 | 32,429 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,770,600 | 29,031 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $967,176 | 17,100 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $799,952 | 15,461 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $364,259 | 8,771 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $211,876 | 3,907 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $210,832 | 4,109 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $249,572 | 4,300 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $253,689 | 3,967 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $2,002,643 | 28,894 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $2,056,978 | 28,589 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $1,785,496 | 25,116 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $274,428 | 3,564 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $231,578 | 3,171 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $279,639 | 4,485 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $186,444 | 3,151 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $229,994 | 3,442 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $197,786 | 3,133 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $204,078 | 3,290 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $235,975 | 3,914 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $229,555 | 3,904 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $203,395 | 3,649 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||